Tag: AMyris

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

June 22, 2017 |

  The Digest discovered this hand-written lyric, we think written with a thumbnail dipped in biocrude, near Amyris headquarters in Emeryville, California. Somewhere north of Byron Bay where Cooktown orchids grow, and cane is ever-present and the Pioneer River flows, there’ll be a group of smarties along the coastal towns hawking tonnes of bio farnesene for a zillion yuan a […]

Read More

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

June 22, 2017 |

  The Digest discovered this hand-written lyric, we think written with a thumbnail dipped in biocrude, near Amyris headquarters in Emeryville, California. Somewhere north of Byron Bay where Cooktown orchids grow, and cane is ever-present and the Pioneer River flows there’ll be a group of smarties along the coastal towns hawking tonnes of bio farnesene for a zillion yuan a […]

Read More

Amyris and Queensland team on commercial-scale biorefineries

Amyris and Queensland team on commercial-scale biorefineries

June 20, 2017 |

In Australia, Amyris, Inc. and the Government of Queensland announced the next step in their plans to develop a leading industrial biotechnology hub in Southeast Asia. Plans call for developing a new production plant with support from local partners to produce Amyris’s sugar cane-based ingredient called farnesene, which is used in products including cosmetic emollients, […]

Read More

T Minus 90. Amyris’ next 90 days will say much, and may say all

T Minus 90. Amyris’ next 90 days will say much, and may say all

May 21, 2017 |

Moving fast, but will escape velocity be reached? Amyris reports 164% product revenue jump — yet questions linger. In California, Amyris reported Q1 revenues of $13.0M compared with $8.8M for Q1 2016, and touted the “significant increase in product sales, primarily in the personal care and health and nutrition markets, offset by a slight decline […]

Read More

First $47 million investment tranche led by Royal DSM into Amyris closed

First $47 million investment tranche led by Royal DSM into Amyris closed

May 15, 2017 |

In California, Amyris, Inc. announced the closing of the first tranche of up to $95 million in planned equity financing that the company previously announced on May 8, 2017. The first tranche was approximately $47 million and was led by Koninklijke DSM N.V. (Royal DSM) with participation by qualified institutional buyers and accredited investors, including […]

Read More

Amyris says “double the revenue” in sight with Nenter Vitamin E Partnership as DSM Vitamin A partnership unveiled

Amyris says “double the revenue” in sight with Nenter Vitamin E Partnership as DSM Vitamin A partnership unveiled

May 11, 2017 |

In California, Amyris said it expects revenue related to its Vitamin E partnership with Nenter to more than double based on the current success of the program. During 2016, the company shipped approximately $9 million of farnesene to Nenter for conversion to Vitamin E and expects 2017 shipments to Nenter to be about $20 million. […]

Read More

DSM invests $25 million in Amyris

DSM invests $25 million in Amyris

May 8, 2017 |

In California, Amyris, Inc. the industrial bioscience company, and Koninklijke DSM N.V., the global science-based company active in health, nutrition and materials, announced that they have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health […]

Read More

DSM invests in Amyris

DSM invests in Amyris

May 8, 2017 |

In California, DSM led a round of investors that will put up to $95 million in equity financing into Amyris via a registered direct offering of convertible preferred stock, and private placements of convertible preferred stock and warrants. Amyris is in the process of reducing its debt by approximately $75 million. DSM has agreed to […]

Read More

Amyris Joins the Sweet Fleet, and DARPA lends a hand

Amyris Joins the Sweet Fleet, and DARPA lends a hand

May 3, 2017 |

Back in September 2015, we reported that Amyris inked a multi-year agreement with the US Defense Advance Research Projects Agency, the famed DARPA that gave us everything from kevlar to the Global Positioning System and the Internet — the goal in this $35M agreement with the Biological Technologies Office was to create new research and […]

Read More

Amyris teams with Blue California to manufacture ingredients in China

Amyris teams with Blue California to manufacture ingredients in China

April 19, 2017 |

In California, Amyris announced that it has expanded the scope of its relationship with Phyto Tech Corp (D/B/A “Blue California”). Blue California is based in Southern California and is a global leader in food, flavor and fragrance ingredients and nutraceuticals. Amyris No Compromise® ingredients into China have been more than doubling in sales and are […]

Read More